Selected research
Market Structure
Global Next-Generation Sequencing (NGS) Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Next-Generation Sequencing (NGS) Kits market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Next-Generation Sequencing (NGS) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Next-Generation Sequencing (NGS) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Next-Generation Sequencing (NGS) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Next-Generation Sequencing (NGS) Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Next-Generation Sequencing (NGS) Kits include Amoydxmed, Foundation Medicine, Illumina, MSKCC, Novogene, Nanjing Geneseeq, Burning Rock Biotech and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Next-Generation Sequencing (NGS) Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Next-Generation Sequencing (NGS) Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Next-Generation Sequencing (NGS) Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Next-Generation Sequencing (NGS) Kits market size, projected growth trends, production technologies, key applications, and end-use industries.
Next-Generation Sequencing (NGS) Kits Segment by Company
Amoydxmed
Foundation Medicine
Illumina
MSKCC
Novogene
Nanjing Geneseeq
Burning Rock Biotech
Thermo Fisher Scientific
Next-Generation Sequencing (NGS) Kits Segment by Type
BRAF
BRCA
EGFR
Others
Next-Generation Sequencing (NGS) Kits Segment by Application
Research Organizations
Hospitals and Clinics
Biopharma Companies
Others
Next-Generation Sequencing (NGS) Kits Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Next-Generation Sequencing (NGS) Kits market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next-Generation Sequencing (NGS) Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next-Generation Sequencing (NGS) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Next-Generation Sequencing (NGS) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- BRAF
- BRCA
- EGFR
- Others
Applications
- Research Organizations
- Hospitals and Clinics
- Biopharma Companies
- Others
Companies covered
- Amoydxmed
- Foundation Medicine
- Illumina
- MSKCC
- Novogene
- Nanjing Geneseeq
- Burning Rock Biotech
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Next-Generation Sequencing (NGS) Kits Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Next-Generation Sequencing (NGS) Kits Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Next-Generation Sequencing (NGS) Kits Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Next-Generation Sequencing (NGS) Kits Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Next-Generation Sequencing (NGS) Kits Market Dynamics
- 2.1 Next-Generation Sequencing (NGS) Kits Industry Trends
- 2.2 Next-Generation Sequencing (NGS) Kits Industry Drivers
- 2.3 Next-Generation Sequencing (NGS) Kits Industry Opportunities and Challenges
- 2.4 Next-Generation Sequencing (NGS) Kits Industry Restraints
3 Next-Generation Sequencing (NGS) Kits Market by Manufacturers
- 3.1 Global Next-Generation Sequencing (NGS) Kits Revenue by Manufacturers (2021-2026)
- 3.2 Global Next-Generation Sequencing (NGS) Kits Sales by Manufacturers (2021-2026)
- 3.3 Global Next-Generation Sequencing (NGS) Kits Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Next-Generation Sequencing (NGS) Kits Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Next-Generation Sequencing (NGS) Kits Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Next-Generation Sequencing (NGS) Kits Manufacturers, Product Type & Application
- 3.7 Global Next-Generation Sequencing (NGS) Kits Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Next-Generation Sequencing (NGS) Kits Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Next-Generation Sequencing (NGS) Kits Players Market Share by Revenue in 2025
- 3.8.3 2025 Next-Generation Sequencing (NGS) Kits Tier 1, Tier 2, and Tier 3
4 Next-Generation Sequencing (NGS) Kits Market by Type
- 4.1 Next-Generation Sequencing (NGS) Kits Type Introduction
- 4.1.1 BRAF
- 4.1.2 BRCA
- 4.1.3 EGFR
- 4.1.4 Others
- 4.2 Global Next-Generation Sequencing (NGS) Kits Sales by Type
- 4.2.1 Global Next-Generation Sequencing (NGS) Kits Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Next-Generation Sequencing (NGS) Kits Sales by Type (2021-2032)
- 4.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Market Share by Type (2021-2032)
- 4.3 Global Next-Generation Sequencing (NGS) Kits Revenue by Type
- 4.3.1 Global Next-Generation Sequencing (NGS) Kits Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Next-Generation Sequencing (NGS) Kits Revenue by Type (2021-2032)
- 4.3.3 Global Next-Generation Sequencing (NGS) Kits Revenue Market Share by Type (2021-2032)
5 Next-Generation Sequencing (NGS) Kits Market by Application
- 5.1 Next-Generation Sequencing (NGS) Kits Application Introduction
- 5.1.1 Research Organizations
- 5.1.2 Hospitals and Clinics
- 5.1.3 Biopharma Companies
- 5.1.4 Others
- 5.2 Global Next-Generation Sequencing (NGS) Kits Sales by Application
- 5.2.1 Global Next-Generation Sequencing (NGS) Kits Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Next-Generation Sequencing (NGS) Kits Sales by Application (2021-2032)
- 5.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Market Share by Application (2021-2032)
- 5.3 Global Next-Generation Sequencing (NGS) Kits Revenue by Application
- 5.3.1 Global Next-Generation Sequencing (NGS) Kits Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Next-Generation Sequencing (NGS) Kits Revenue by Application (2021-2032)
- 5.3.3 Global Next-Generation Sequencing (NGS) Kits Revenue Market Share by Application (2021-2032)
6 Global Next-Generation Sequencing (NGS) Kits Sales by Region
- 6.1 Global Next-Generation Sequencing (NGS) Kits Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Next-Generation Sequencing (NGS) Kits Sales by Region (2021-2032)
- 6.2.1 Global Next-Generation Sequencing (NGS) Kits Sales by Region (2021-2026)
- 6.2.2 Global Next-Generation Sequencing (NGS) Kits Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Next-Generation Sequencing (NGS) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Next-Generation Sequencing (NGS) Kits Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Next-Generation Sequencing (NGS) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Next-Generation Sequencing (NGS) Kits Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Next-Generation Sequencing (NGS) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Next-Generation Sequencing (NGS) Kits Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Next-Generation Sequencing (NGS) Kits Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Next-Generation Sequencing (NGS) Kits Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Next-Generation Sequencing (NGS) Kits Revenue by Region
- 7.1 Global Next-Generation Sequencing (NGS) Kits Revenue by Region
- 7.1.1 Global Next-Generation Sequencing (NGS) Kits Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Next-Generation Sequencing (NGS) Kits Revenue by Region (2021-2026)
- 7.1.3 Global Next-Generation Sequencing (NGS) Kits Revenue by Region (2027-2032)
- 7.1.4 Global Next-Generation Sequencing (NGS) Kits Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Next-Generation Sequencing (NGS) Kits Revenue (2021-2032)
- 7.2.2 North America Next-Generation Sequencing (NGS) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Next-Generation Sequencing (NGS) Kits Revenue (2021-2032)
- 7.3.2 Europe Next-Generation Sequencing (NGS) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Next-Generation Sequencing (NGS) Kits Revenue (2021-2032)
- 7.4.2 Asia-Pacific Next-Generation Sequencing (NGS) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Next-Generation Sequencing (NGS) Kits Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Next-Generation Sequencing (NGS) Kits Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Amoydxmed
- 8.1.1 Amoydxmed Company Information
- 8.1.2 Amoydxmed Business Overview
- 8.1.3 Amoydxmed Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Amoydxmed Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.1.5 Amoydxmed Recent Developments
- 8.2 Foundation Medicine
- 8.2.1 Foundation Medicine Company Information
- 8.2.2 Foundation Medicine Business Overview
- 8.2.3 Foundation Medicine Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Foundation Medicine Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.2.5 Foundation Medicine Recent Developments
- 8.3 Illumina
- 8.3.1 Illumina Company Information
- 8.3.2 Illumina Business Overview
- 8.3.3 Illumina Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Illumina Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.3.5 Illumina Recent Developments
- 8.4 MSKCC
- 8.4.1 MSKCC Company Information
- 8.4.2 MSKCC Business Overview
- 8.4.3 MSKCC Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 MSKCC Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.4.5 MSKCC Recent Developments
- 8.5 Novogene
- 8.5.1 Novogene Company Information
- 8.5.2 Novogene Business Overview
- 8.5.3 Novogene Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Novogene Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.5.5 Novogene Recent Developments
- 8.6 Nanjing Geneseeq
- 8.6.1 Nanjing Geneseeq Company Information
- 8.6.2 Nanjing Geneseeq Business Overview
- 8.6.3 Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.6.5 Nanjing Geneseeq Recent Developments
- 8.7 Burning Rock Biotech
- 8.7.1 Burning Rock Biotech Company Information
- 8.7.2 Burning Rock Biotech Business Overview
- 8.7.3 Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.7.5 Burning Rock Biotech Recent Developments
- 8.8 Thermo Fisher Scientific
- 8.8.1 Thermo Fisher Scientific Company Information
- 8.8.2 Thermo Fisher Scientific Business Overview
- 8.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.8.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Next-Generation Sequencing (NGS) Kits Value Chain Analysis
- 9.1.1 Next-Generation Sequencing (NGS) Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Next-Generation Sequencing (NGS) Kits Production Mode & Process
- 9.2 Next-Generation Sequencing (NGS) Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Next-Generation Sequencing (NGS) Kits Distributors
- 9.2.3 Next-Generation Sequencing (NGS) Kits Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst